LabCorp
LH
$205.98
Share price
3.82%
Change (1 day)
-9.14%
Change (1 year)
Categories
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.
Market capitalization of LabCorp (LH)
Market cap: $17.36 Billion
As of April 2024 LabCorp has a market cap of $17.36 Billion. This makes LabCorp the world's 1055th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of LabCorp from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $17.36 B | -10.02% |
| 2023 | $19.29 B | -7.51% |
| 2022 | $20.86 B | -30.62% |
| 2021 | $30.06 B | 51.67% |
| 2020 | $19.82 B | 20.57% |
| 2019 | $16.44 B | 31.58% |
| 2018 | $12.49 B | -23.04% |
| 2017 | $16.23 B | 22.8% |
| 2016 | $13.22 B | 5.58% |
| 2015 | $12.52 B | 37.21% |
| 2014 | $9.12 B | 16.58% |
| 2013 | $7.83 B | -3.32% |
| 2012 | $8.09 B | -4.94% |
| 2011 | $8.51 B | -5.37% |
| 2010 | $9.00 B | 14.24% |
| 2009 | $7.88 B | 13.29% |
| 2008 | $6.95 B | -17.03% |
| 2007 | $8.38 B | -6.62% |
| 2006 | $8.97 B | 31.8% |
| 2005 | $6.81 B | 0.39% |
| 2004 | $6.78 B | 28.12% |
| 2003 | $5.29 B | 54.25% |
| 2002 | $3.43 B | -39.81% |
| 2001 | $5.70 B |
End of Day market cap according to different sources
On Apr 28th, 2024 the market cap of LabCorp was reported to be:
$16.72 Billion
$16.72 Billion
$16.68 Billion
$16.69 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | $42.00 B | 141.91% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $15.69 B | -9.62% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $2.82 B | -83.74% | 🇺🇸 USA |
 NeoGenomics
NEO | $1.95 B | -88.72% | 🇺🇸 USA |
 Qiagen QGEN | $9.32 B | -46.32% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $54.29 M | -99.69% | 🇺🇸 USA |